Craneware maintains momentum into new financial year
By Josh White
Date: Friday 21 Nov 2025
(Sharecast News) - Craneware said in an update on Friday that trading at the start of its new financial year maintained the momentum reported in 2025, with its alliance with Microsoft helping to expand the sales pipeline and support product innovation.
In a statement released ahead of its annual general meeting on Friday, the healthcare financial software group said US providers remain focused on improving operational and financial performance, which is sustaining demand for its solutions.
The AIM-traded company highlighted ongoing investment in research and development, aimed at strengthening its product set and extending its use of proprietary data across its platform.
A key recent initiative had been the accelerated launch of a product to help hospitals manage the US government's new 340B drug rebate pilot programme.
Under the scheme, which starts on 1 January, participating hospitals would need to purchase an initial set of nine drugs at wholesale cost and then apply for rebates, adding administrative and compliance burdens.
Craneware said its early investment in the Trisus platform and its "unique position of independence in the 340B vendor market" enabled it to bring a fully integrated solution to market in an unusually short timeframe.
The product had already been demonstrated to customers through live meetings and webinars, and was now being rolled out ahead of the deadline.
Craneware said the new system supported customers "by reducing their financial risk, maintaining compliance and protecting resources for patient care", adding that the launch is "a testament to Craneware's leading position in the 340B market."
The firm also confirmed several board changes.
Senior non-executive director David Kemp would retire after the annual general meeting, having chosen not to stand for re-election.
Craneware thanked him for his long service, saying "his insight and constructive challenge have been invaluable, helping drive Craneware's success."
After the meeting, Alistair Erskine would become senior independent director, Susan Nelson would chair the audit committee and Jill Goldsmith would take over as company secretary.
Craneware said its annuity-style software-as-a-service model, strong balance sheet, recurring revenue base and cash generation continue to underpin its growth strategy.
The board said it "remains confident in the delivery of continued growth over the near term" and confirmed the group was trading in line with market expectations for the year.
At 0945 GMT, shares in Craneware were up 1.32% at 2,147.9p.
Reporting by Josh White for Sharecast.com.
Email this article to a friend
or share it with one of these popular networks:
You are here: news
10 Lower Thames St,
London EC3R 6EN